FRAXIPARINE
Google image searchProduct monograph
Active ingredient
nadroparin calcium, 9500 UNIT/ML
DIN: 02450631
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS
Description: 0.6 ML (5700 IU) PREFILLED SYRINGE - BROWN
Schedule: Prescription
Company: ASPEN PHARMACARE CANADA INC.
Date: 05-DEC-2018
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AB — Heparin group (ATC, ATC/DDD)
- B01AB06 — NADROPARIN (ATC/DDD)
Reference brand drug: Fraxiparine
